Pediatric SuperSite says Advertising Though PediatricSuperSite.com is supported by advertising, its acceptance of advertising in no way implies endorsement by the editors, publisher or editorial boards. All advertisements appearing on PediatricSuperSite.com are placed in fixed positions that are predetermined. The positioning of advertisements is not related to editorial content or known in advance of an article's publication; any appearance otherwise is simply coincidence. Like this RotaTeq ad in two locations on the screen along with an article about Dr. Paul Offit, who sold the patent for the vaccine. Ah, serendipity! Sometimes it really is better to be lucky than good!
Click the photo to increase size. To learn we find this ironic, read Voting Himself Rich: CDC Vaccine Adviser Made $29 Million Or More After Using Role to Create Market.
Voting Himself Rich: CDC Vaccine Adviser Made $29 Million Or More After Using Role to Create Market
Omnibus autism decision: ‘Good science wins out in the end’
Every year, Infectious Diseases in Children’s editorial board votes on the top stories of the previous year, and this year, the Omnibus Autism decision topped the list.
...Paul Offit, MD, Chief of Infectious Diseases at Children’s Hospital of Philadelphia and a member of the editorial board, provided an overview of these proceedings at the 22nd Annual Infectious Diseases in Children Symposium in New York this weekend.
In his presentation, Offit noted that Andrew Wakefield, the physician who sparked the initial scare over the safety of the MMR vaccine for children, misreported results in his research, creating the appearance of a possible link with autism, which led to many of these lawsuits. Several studies involving thousands of children have since refuted this link.
Offit said he believes that a recommendation to remove thimerosol from vaccines, despite evidence that showed a connection to autism, galvanized beliefs in that connection. Several studies that Offit mentioned, however, refuted this link.
Offit said the ruling of the special masters in February “came out on the side of science.”